Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Buy
1,784
+884
+98% +$190K 0.29% 29
2026
Q1
$196K Hold
900
0.15% 39
2025
Q4
$206K Sell
900
-23
-2% -$5.24K 0.15% 39
2025
Q3
$214K Sell
923
-321
-26% -$65.4K 0.16% 38
2025
Q2
$231K Buy
1,244
+800
+180% +$149K 0.19% 33
2025
Q1
$93K Hold
444
0.08% 46
2024
Q4
$78.9K Hold
444
0.07% 51
2024
Q3
$87.7K Sell
444
-42
-9% -$7.84K 0.07% 51
2024
Q2
$78.4K Buy
486
+23
+5% +$3.81K 0.07% 47
2024
Q1
$81.5K Sell
463
-16
-3% -$2.76K 0.07% 49
2023
Q4
$68.2K Hold
479
0.07% 51
2023
Q3
$71.4K Hold
479
0.07% 54
2023
Q2
$64.5K Sell
479
-62
-11% -$9.09K 0.06% 61
2023
Q1
$83.3K Hold
541
0.09% 55
2022
Q4
$87K Hold
541
0.09% 58
2022
Q3
$73K Buy
541
+120
+29% +$17.2K 0.09% 58
2022
Q2
$64K Hold
421
0.07% 67
2022
Q1
$68K Buy
421
+100
+31% +$14.5K 0.07% 70
2021
Q4
$43K Hold
321
0.04% 95
2021
Q3
$35K Hold
321
0.04% 97
2021
Q2
$36K Buy
+321
New +$36.2K 0.04% 97

Other funds holding ABBV

Hoese & Co's ABBV Position: Q2 2026 in Review

Hoese & Co increased its AbbVie (ABBV) stake by 98% in Q2 2026, buying an estimated $190K and bringing the position to 1,784 shares worth $449K. The position accounts for 0.29% of the portfolio, ranked #29.

Hoese & Co first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hoese & Co held 1,784 shares of AbbVie worth $449K as of Q2 2026.
  • Hoese & Co bought 884 AbbVie shares in Q2 2026, an estimated $190K.
  • AbbVie made up 0.29% of Hoese & Co's portfolio in Q2 2026, its #29 holding.
  • Hoese & Co first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.